What is the dosage for Labetalol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Labetalol Dosing

For hypertensive emergencies, administer labetalol 10-20 mg IV over 1-2 minutes, repeating or doubling every 10-20 minutes up to a maximum cumulative dose of 300 mg, or alternatively use a continuous infusion at 2-8 mg/min. 1

Intravenous Dosing for Hypertensive Emergencies

Acute Ischemic Stroke

For patients NOT eligible for thrombolytic therapy:

  • Systolic >220 mmHg or diastolic 121-140 mmHg: Labetalol 10-20 mg IV over 1-2 minutes, may repeat or double every 10 minutes to maximum dose of 300 mg 1
  • Target: 10-15% reduction in blood pressure 1, 2

For patients ELIGIBLE for thrombolytic therapy:

  • Pre-treatment (systolic >185 mmHg or diastolic >110 mmHg): Labetalol 10-20 mg IV over 1-2 minutes, may repeat once 1, 2
  • During/after treatment (systolic 180-230 mmHg or diastolic 105-120 mmHg): Labetalol 10 mg IV over 1-2 minutes, may repeat or double every 10-20 minutes to maximum 300 mg, OR initial 10 mg IV followed by infusion at 2-8 mg/min 1, 2
  • During/after treatment (systolic >230 mmHg or diastolic 121-140 mmHg): Same dosing as above 1, 2
  • Goal: Maintain blood pressure <185/110 mmHg before administering rtPA 1, 2

Other Hypertensive Emergencies

  • Non-stroke emergencies: Initial dose 0.3-1.0 mg/kg (maximum 20 mg) slow IV injection every 10 minutes, maximum cumulative dose 300 mg, may repeat every 4-6 hours 2
  • Acute aortic disease: Target systolic BP ≤120 mmHg and heart rate ≤60 bpm 3
  • Hemorrhagic stroke: Target systolic BP <180 mmHg 3
  • Severe pre-eclampsia/eclampsia: First-line therapy with target systolic <160 mmHg and diastolic <105 mmHg; cumulative dose should not exceed 800 mg/24h to prevent fetal bradycardia 3

Oral Dosing for Chronic Hypertension

Initial dose: 100 mg twice daily, whether used alone or with a diuretic 4

Titration: After 2-3 days, increase in increments of 100 mg twice daily every 2-3 days based on standing blood pressure 4

Usual maintenance: 200-400 mg twice daily 4

Severe hypertension: May require 1,200-2,400 mg per day 4

Maximum dose: 2,400 mg daily 2, 4

Alternative dosing for side effects: If nausea or dizziness occurs with twice-daily dosing, divide the same total daily dose into three times daily; titration increments should not exceed 200 mg twice daily 4

Elderly patients: Initiate at 100 mg twice daily and titrate upwards in 100 mg increments; most elderly patients require only 100-200 mg twice daily due to slower elimination 4

Pregnancy: May require three or four times daily dosing due to accelerated drug metabolism during pregnancy 2

Monitoring Requirements

For thrombolytic therapy patients: Check blood pressure every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then every hour for 16 hours 1

For hemorrhagic stroke: Monitor blood pressure every 15 minutes until stabilized for the first 24-48 hours 3

General monitoring: The full antihypertensive effect is usually seen within 1-3 hours of initial dose or dose increment 4

Critical Contraindications

Absolute contraindications:

  • Second or third-degree heart block 3, 2
  • Bradycardia 3
  • Decompensated heart failure 3, 2
  • Reactive airways disease or COPD 2

Important Clinical Pearls

  • Labetalol is particularly useful in hyperadrenergic states due to its combined alpha- and beta-blocking properties 3, 2
  • In hypertensive encephalopathy, labetalol may be preferred as it leaves cerebral blood flow relatively intact compared to nitroprusside 3
  • When adding a diuretic, expect an additive antihypertensive effect that may necessitate dose reduction 4
  • High-dose IV labetalol (>300 mg/24h) has been studied with mean doses of 996 mg showing 44% adverse event rate (primarily bradycardia 36.5% and hypotension 18.6%), but only 2.7% required rescue agents, suggesting these events rarely cause clinically significant hemodynamic compromise 5
  • Fluid retention is frequent but easily controlled with diuretics 6
  • Abrupt discontinuation does not cause blood pressure overshoot 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Labetalol Dosing for Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Severe Hypertension with Labetalol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Safety of high-dose intravenous labetalol in hypertensive crisis.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.